MICHAEL CHOI: Open Payments
NPI 1194048827 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$107 in 3 payments from 2 companies in 2025. Trend: 2023 $273 · 2024 $405 · 2025 $107
Food & beverage: $107
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 2 | $75 |
| Alkermes, Inc. | 1 | $31 |
Products named: INGREZZA, ARISTADA.
Industry payments across CA — which companies pay providers there.
